Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size.
Xueyu ZhaoXiaojun DaiShanshan WangTing YangYan YanGuang ZhuJun FengBo PanMasataka SunagawaXiao-Chun ZhangYayun QianYan-Qing LiuPublished in: Evidence-based complementary and alternative medicine : eCAM (2018)
Adjuvant therapy with TCM may reduce the rate of tumor recurrence and metastasis and prolong DFS of patients with stage II-IIIA NSCLC.